{"id":18752,"date":"2016-02-03T13:54:25","date_gmt":"2016-02-03T12:54:25","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=18752"},"modified":"2016-02-03T13:54:25","modified_gmt":"2016-02-03T12:54:25","slug":"cap-a-una-millor-gestio-del-dolor-cronic-oncologic","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","title":{"rendered":"Hacia una mejor gesti\u00f3n del dolor cr\u00f3nico no oncol\u00f3gico"},"content":{"rendered":"

El dolor est\u00e1 entre los primeros trastornos cr\u00f3nicos declarados por la poblaci\u00f3n, con afectaci\u00f3n importante de la calidad de vida de las personas que lo padecen. La prevalencia del dolor cr\u00f3nico en la poblaci\u00f3n adulta en Espa\u00f1a es del 23,4% y superior en las mujeres y en el grupo de m\u00e1s edad. El dolor es un s\u00edntoma que est\u00e1 presente en muchas enfermedades<\/b> y, por tanto, las propuestas para mejorar su gesti\u00f3n son objetivos de los diferentes profesionales sanitarios en la atenci\u00f3n primaria y especializada<\/b> que intervienen en la estrategia del tratamiento para mejorar la calidad de la atenci\u00f3n a los pacientes con dolor, en ocasiones, dolor cr\u00f3nico complejo o de dif\u00edcil tratamiento. Por otro lado, el dolor cr\u00f3nico tiene importantes costes asociados tanto por el incremento de la utilizaci\u00f3n de servicios sanitarios como por el aumento de la prescripci\u00f3n de f\u00e1rmacos y por la p\u00e9rdida de d\u00edas de trabajo. Por eso se hac\u00eda conveniente hacer una revisi\u00f3n de las estrategias de tratamiento y de la gesti\u00f3n cl\u00ednica del paciente.<\/p>\n

\"curs-dolor-cronic-no-oncologic<\/a>
Roser Vall\u00e8s, vocal de Atenci\u00f3n Primaria del COFB<\/figcaption><\/figure>\n

En torno a esta cuesti\u00f3n se organiz\u00f3 la sesi\u00f3n \u201cGesti\u00f3n del dolor cr\u00f3nico no oncol\u00f3gico\u201d, que tuvo lugar el pasado 2 de diciembre en el COFB, una reflexi\u00f3n conjunta de diferentes especialistas con puntos de vista diversos sobre la gesti\u00f3n del dolor cr\u00f3nico oncol\u00f3gico. El encuentro, impulsado por el Colegio conjuntamente con el Sociedad Catalana de Farmacia Cl\u00ednica<\/a> (SCFC) y la Sociedad Espa\u00f1ola de Farmac\u00e9uticos de Atenci\u00f3n Primaria<\/a> (SEFAP), ten\u00eda por objetivo dar a conocer la evidencia cient\u00edfica de los diferentes tratamientos para gestionar el dolor cr\u00f3nico no oncol\u00f3gico y facilitar el abordaje del dolor cr\u00f3nico desde la atenci\u00f3n primaria y cu\u00e1les son los criterios de derivaci\u00f3n a la especializada y de gesti\u00f3n. Tambi\u00e9n saber c\u00f3mo aborda esta patolog\u00eda la unidad de dolor del hospital, cu\u00e1les son los tratamientos que prescribe y los criterios de selecci\u00f3n terap\u00e9uticos y c\u00f3mo la fisioterapia puede contribuir a mejorar la calidad de vida del paciente, mermar el dolor o recuperar funcionalmente la parte del cuerpo afectada.<\/p>\n

Roser Vall\u00e8s, vocal de Atenci\u00f3n Primaria del COFB<\/b>, y una de las coordinadoras de la formaci\u00f3n, junto con Tom\u00e0s Casas\u00edn (vocal de Hospitales del COFB), Rosa Madridejos (vocal en Catalu\u00f1a de SEFAP), Julio Mart\u00ednez Cutillas (presidente de la SCFC), resume los puntos m\u00e1s destacados de las intervenciones del equipo docente:<\/p>\n[caption id="attachment_18755" align="alignleft" width="298"]\"curs-dolor-cronic-no-oncologic<\/a> La farmac\u00e9utica Laura Diego (CedimCat) y la m\u00e9dica Esther Lim\u00f3n (EAP Matar\u00f3)[\/caption]\n

Evidencia cient\u00edfica de los distintos tratamientos utilizados en el tratamiento del dolor.<\/b> Como punto de partida, la evidencia cient\u00edfica sobre c\u00f3mo realizar el abordaje de este problema de salud, diferente al que se hace con otros tipos de dolor. Sin embargo Laura Diego<\/b>, farmac\u00e9utica coordinadora del Centro de Informaci\u00f3n de Medicamentos de Catalu\u00f1a (CedimCat), explic\u00f3 que tenemos aspectos por los que la evidencia cient\u00edfica todav\u00eda no tiene respuesta, como ser\u00eda la eficacia comparada entre los distintos f\u00e1rmacos.<\/p>\n

\u00bfC\u00f3mo hace el abordaje del dolor cr\u00f3nico no oncol\u00f3gico la atenci\u00f3n primaria? \u00bfY una unidad de dolor hospitalaria? <\/b>Esta evidencia cient\u00edfica se aplica en el d\u00eda a d\u00eda de la consulta de atenci\u00f3n primaria y de la atenci\u00f3n especializada en las unidades del dolor, como comentaron las m\u00e9dicas Esther Lim\u00f3n, <\/b>m\u00e9dica de familia del EAP Matar\u00f3-7 del ICS, miembro del grupo ATDOM de la CAMFiC y responsable del grupo de cuidados paliativos de la semFYC, y Maria Victoria Ribera<\/b>, jefe de la Unidad de Dolor del Hospital Universitario del Vall d'Hebron. Sin embargo, hay que tener en cuenta siempre que el tratamiento debe individualizarse y pactar con cada paciente marcando objetivos realistas<\/b> por no crear falsas expectativas (la desaparici\u00f3n total del dolor cr\u00f3nico no oncol\u00f3gico en la mayor\u00eda de los casos es pr\u00e1cticamente imposible).<\/p>\n[caption id="attachment_18759" align="alignright" width="298"]\"curs-dolor-cronic-no-oncologic<\/a> La m\u00e9dica Maria Victoria Ribera (Hospital Universitario del Vall d'Hebron) y la fisioterapeuta Carme S\u00e1nchez (Servicio Rehabilitaci\u00f3n de Matar\u00f3)[\/caption]\n

Abordaje no farmacol\u00f3gico del dolor cr\u00f3nico.<\/b> En este abordaje integral son muy importantes los tratamientos no farmacol\u00f3gicos<\/b> y muchas veces son la soluci\u00f3n del problema. Algunas unidades del dolor tienen integrados psic\u00f3logos y fisioterapeutas que ofrecen tratamientos complementarios o en ocasiones sustitutos a los tratamientos farmacol\u00f3gicos. Los servicios de rehabilitaci\u00f3n ofrecen instalaciones con nuevos equipamientos que forman parte del abordaje integral del dolor, tal y como mostr\u00f3 Carme S\u00e1nchez<\/b>, fisioterapeuta del Servicio de Rehabilitaci\u00f3n de Matar\u00f3.<\/p>\n

\u201cTodos los ponentes coincidieron en afirmar que es necesaria una mejora en la coordinaci\u00f3n de todos los servicios que ofrecemos a los pacientes<\/strong> teniendo en cuenta todos los niveles asistenciales<\/strong>, desde las unidades especializadas pasando por la atenci\u00f3n primaria y la farmacia comunitaria. Es importante individualizar y adecuar el tratamiento de cada paciente<\/strong> pactando con \u00e9l y fomentando tambi\u00e9n su autocuidado\u201d explica Vall\u00e8s.<\/div><\/b><\/p>\n

La sesi\u00f3n, a la que asistieron farmac\u00e9uticos de atenci\u00f3n primaria, de hospitales y de la administraci\u00f3n sanitaria, pudo seguirse presencialmente o en directo online, v\u00eda conexi\u00f3n Webinar.<\/p>\n

\"curs-dolor-cronic-no-oncologic<\/a>
Asistentes a la sesi\u00f3n presencial en el Colegio<\/figcaption><\/figure>\n

Con la colaboraci\u00f3n de:<\/b><\/p>\n

\"esteve\"<\/a><\/b><\/p>","protected":false},"excerpt":{"rendered":"

El dolor est\u00e1 entre los primeros trastornos cr\u00f3nicos declarados por la poblaci\u00f3n, con afectaci\u00f3n importante de la calidad de vida de las personas que lo padecen. La prevalencia del dolor cr\u00f3nico en la poblaci\u00f3n adulta en Espa\u00f1a es del 23,4% y superior en las mujeres y en el grupo [\u2026]<\/p>","protected":false},"author":1,"featured_media":18758,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2307,938,2308,480],"class_list":["post-18752","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-abordatge-terapeutic","tag-atencio-primaria","tag-dolor-cronic","tag-farmacia-hospitalaria"],"yoast_head":"\nCap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"og:description\" content=\"El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-02-03T12:54:25+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic\",\"datePublished\":\"2016-02-03T12:54:25+00:00\",\"dateModified\":\"2016-02-03T12:54:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\"},\"wordCount\":959,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"abordatge terap\u00e8utic\",\"Atenci\u00f3 prim\u00e0ria\",\"dolor cr\u00f2nic\",\"farm\u00e0cia hospital\u00e0ria\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\",\"name\":\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2016-02-03T12:54:25+00:00\",\"dateModified\":\"2016-02-03T12:54:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","og_locale":"es_ES","og_type":"article","og_title":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","og_description":"El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup […]","og_url":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2016-02-03T12:54:25+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic","datePublished":"2016-02-03T12:54:25+00:00","dateModified":"2016-02-03T12:54:25+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/"},"wordCount":959,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage"},"thumbnailUrl":"","keywords":["abordatge terap\u00e8utic","Atenci\u00f3 prim\u00e0ria","dolor cr\u00f2nic","farm\u00e0cia hospital\u00e0ria"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","url":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/","name":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic - Col\u00b7legi de Farmac\u00e8utics de Barcelona","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage"},"thumbnailUrl":"","datePublished":"2016-02-03T12:54:25+00:00","dateModified":"2016-02-03T12:54:25+00:00","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2016\/02\/03\/cap-a-una-millor-gestio-del-dolor-cronic-oncologic\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Cap a una millor gesti\u00f3 del dolor cr\u00f2nic no oncol\u00f2gic"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"El dolor est\u00e0 entre els primers trastorns cr\u00f2nics declarats per la poblaci\u00f3, amb afectaci\u00f3 important de la qualitat de vida de les persones que el pateixen. La prevalen\u00e7a del dolor cr\u00f2nic en la poblaci\u00f3 adulta a l\u2019estat espanyol \u00e9s del 23,4% i superior en les dones i en el grup […]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/18752","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=18752"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/18752\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=18752"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=18752"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=18752"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}